Preview Mode Links will not work in preview mode

Apr 2, 2021

Proceedings from the first of 2 sessions on triple-negative breast cancer. Featuring perspectives from Dr P Kelly Marcom, including the following topics:

  • Introduction and Review of San Antonio Breast Cancer Symposium 2020 Educational Session on Triple-Negative Breast Cancer (TNBC) (0:00)
  • Optimal Integration of Immune Checkpoint Inhibitors into the Management of Metastatic TNBC (7:41)
  • Novel Applications of Immune Checkpoint Inhibitors for Patients with Early TNBC (19:13)
  • Current and Future Role of PARP Inhibitors for Patients with TNBC and a BRCA Mutation (32:09)
  • Current and Future Management of PD-L1-Negative Metastatic TNBC (52:20)

CME information and select publications